-
Posted by
Two Blokes Jul 10 -
Filed in
Stock
-
8 views
India's Glenmark Pharmaceuticals said on Thursday its innovation arm, Ichnos Glenmark Innovation (IGI), and AbbVie have signed an exclusive global licensing agreement for IGI's cancer treatment, ISB 2001.
